BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114227
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114227
Table 1 Baseline demographic and etiological characteristics of patients with acute pancreatitis stratified by admission serum phosphate levels
Characteristic
Entire cohort (n = 1000)
Hypophosphatemia (< 2.5 mg/dL, n = 150)
Normophosphatemia (2.5-4.5 mg/dL, n = 750)
Hyperphosphatemia (> 4.5 mg/dL, n = 100)
P value
Age, median (IQR), years55 (45-64)54 (43–63)53 (44–62)60 (50–68)0.02
Male sex550 (55.0)80 (53.3)400 (53.3)65 (65.0)0.03
Gallstone-related AP600 (60.0)90 (60.0)480 (64.0)40 (40.0)< 0.001
Table 2 Clinical outcomes according to admission serum phosphate levels
Clinical outcome
Hypophosphatemia (< 2.5 mg/dL, n = 150)
Normophosphatemia (2.5-4.5 mg/dL, n = 750)
Hyperphosphatemia (> 4.5 mg/dL, n = 100)
P value
Severe acute pancreatitis60 (40)150 (20)60 (60)< 0.001
Pancreatic necrosis30 (20)75 (10)50 (50)< 0.001
ICU requirement45 (30)113 (15)70 (70)< 0.001
Length of hospital stay, median (days)10714< 0.001
30-day mortality8 (5)23 (3)25 (25)< 0.001
Table 3 Severity classification of acute pancreatitis according to the revised Atlanta criteria
Severity category (revised Atlanta Classification)
n (%)
Mild/moderately severe AP750 (75)
SAP250 (25)
Table 4 Multivariable-adjusted outcomes according to admission phosphate levels
Outcome
Crude (hyper vs normo) (%)
Adjusted OR (95%CI)
P value
Severe AP60 vs 204.2 (2.3-7.8)< 0.001
Pancreatic necrosis50 vs 105.9 (3.1-11.2)< 0.001
ICU requirement70 vs 156.5 (3.8-12.0)< 0.001
30-day mortality25 vs 35.8 (2.9-11.5)< 0.001